John Nicholas Lukens

faculty photo

John Nicholas Lukens, M.D.

Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
Department: Radiation Oncology

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
2-West
Philadelphia, PA 19104
Office: 215-662-6567
Education:
BA ((Distinction in History))
Yale University, 1999.
MD
University of Pennsylvania School of Medicine, 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

My clinical expertise is in the treatment of head and neck cancers and gastrointestinal cancers. Additionally, I have specialized training in brachytherapy, which consists of placing radioactive sources within, or directly adjacent to a tumor, as a means of delivering highly targeted radiation. I have experience in head and neck, prostate, and gastrointestinal brachytherapy, as well as intra-operative radiotherapy. I have a particular clinical interest in the re-treatment of patients who have undergone a prior course of radiation, through the integration of highly targeted techniques such as proton therapy and brachytherapy. I believe strongly in the importance of an interdisciplinary approach, and work closely with my surgical and medical oncology colleagues to optimize patient outcomes.

Description of Research Expertise

My research focuses on the multidisciplinary management of head and neck cancers, in particular novel strategies to understand and mitigate the toxicities associated with head and neck radiotherapy. Additionally, I am interested in identifying subsets of patients with HPV+ cancer who may benefit from treatment de-intensification, and conversely, those with high-risk disease who may benefit from novel targeted therapy and/or immunotherapy.

Selected Publications

Sannigrahi MK, Raghav L, Rich DJ, Schrank TP, Califano JA, Lukens JN, Sun L, Morgan IM, Cohen RB, Lin A, Liu X, Brown EJ, You J, Mirabello L, Mishra SK, Shimunov D, Brody RM, Pearson AT, Gimotty PA, Diab A, Jalaly JB, Basu D: Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instability. bioRxiv 4: 2024.10.31.621311, Nov 2024.

Hanna GJ, Jabalee J, Lukens JN, Sun L, Rettig EM, Ferrandino R 2nd, Posner MR, Misiukiewicz KJ, Routman DM, Van Abel KM, Del Vecchio Fitz C, Roof SA: Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA in Recurrent, Metastatic HPV-driven Oropharyngeal Cancer Oral Oncology Oral Oncology 158: 107002, Nov 2024.

Pepin A, Kiess A, Lukens JN, Mulugeta P, Taunk NK.: Management of Dry Mouth Toxicity Following 177Lu-PSMA-617 Radioligand Therapy. Pract Radiat Oncol. S1879-8500(24): 00299-6, Nov 2024.

Su W, Anstadt EJ, Gupta N, Groover M, Forrester V, Wang X, Krausz A, Schoenfeld J, Koyfman S, Vidimos A, Stevenson M, Carucci J, Ruiz ES, Lukens JN: Definitive Radiotherapy is a Viable Treatment for Locally Advanced Basal Cell Carcinoma Otherwise Requiring Radical or Disfiguring Resection. International Journal of Radiation Oncology, Biology, Physics S0360-3016(24): 03408-4, Sep 2024 Notes: epub ahead of print.

Patel AM, Haleem A, Maxwell R, Lukens JN, Lin A, Brody RM, Brant JA, Carey RM: Choice of Adjuvant Radiotherapy Facility in Major Salivary Gland Cancer. Laryngoscope 134(8): 3620-3632, Aug 2024.

Groover M, Gupta N, Granger E, Forrester VJ, Anstadt EJ, Su W, Heusinkveld L, Lukens JN, Silk AW, Schoenfeld JD, Koyfman SA, Vidimos AT, Ruiz ES: Patterns of metastasis from a multicenter cohort of metastatic basal cell carcinoma. J Am Acad Dermatol 90(6): 1252-1254, Jun 2024.

Bakhtiar M, Butala AA, Berlin EE, Metz JM, Bradley JD, Jones JA, Lukens JN, Paydar I, Taunk NK: Factors Associated With and Characteristics of Patients Receiving Proton Therapy at the End of Life. Int J Part Ther 11, Apr 2024.

Schmults CD, Blitzblau R, Aasi SZ, Alam M, Amini A, Bibee K, Bolotin D, Bordeaux J, Chen PL, Contreras CM, DiMaio D, Donigan JM, Farma JM, Ghosh K, Harms K, Ho AL, Lukens JN, Manber S, Mark L, Medina T, Nehal KS, Nghiem P, Olino K, Park S, Patel T, Puzanov I, Rich J, Sekulic A, Shaha AR, Srivastava D, Thomas V, Tomblinson C, Venkat P, Xu YG, Yu S, Yusuf M, McCullough B, Espinosa S: NCCN GuidelinesĀ® Insights: Merkel Cell Carcinoma, Version 1.2024. J Natl Compr Canc Netw 22(1D), Jan 2024.

Groover M, Gupta N, Granger E, Murad F, Forrester VJ, Anstadt EJ, Su W, Heusinkveld L, Lukens JN, Silk AW, Schoenfeld JD, Koyfman SA, Ruiz ES, Vidimos AT: A multicenter retrospective cohort analysis of advanced basal cell carcinoma outcomes by sex. J Am Acad Dermatol 90(1): 137-139, Jan 2024.

Ma KL, Sharon CE, Tortorello GN, Keele L, Lukens JN, Karakousis GC, Miura JT: Delayed time to radiation and overall survival in Merkel cell carcinoma. J Surg Oncol 128(8): 1385-1393, Dec 2023.

back to top
Last updated: 12/20/2024
The Trustees of the University of Pennsylvania